Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8226507 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 7 Pages |
Abstract
Concurrent chemoradiotherapy for esophageal cancer impairs LVF from an early treatment stage. This impairment is prominent in patients with high LV dose.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Masamitsu M.D., Ph.D., Masato M.D., Takeshi M.D., Katsumasa M.D., Ph.D., Hidetake M.D., Ph.D., Yoshiyuki M.D., Ph.D., Michinobu M.D., Ph.D., Yoshio M.D., Ph.D., Takeshi M.D., Taiki M.D., Kei R.T., Taro M.D., Hiroshi M.D., Ph.D.,